US Stock MarketDetailed Quotes

SHPH Shuttle Pharmaceuticals

Watchlist
  • 0.700
  • +0.009+1.26%
Close Feb 14 16:00 ET
  • 0.707
  • +0.007+0.99%
Post 20:01 ET
2.85MMarket Cap-0.16P/E (TTM)

About Shuttle Pharmaceuticals Company

Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery, radiation therapy, chemotherapy, and immunotherapy. The company was founded by Anatoly Dritschilo, Mira Jung, and Milton Brown on December 18, 2012 and is headquartered in Gaithersburg, MD.

Company Profile

SymbolSHPH
Company NameShuttle Pharmaceuticals
Listing DateAug 31, 2022
Issue Price8.12
Founded2012
CEODr. Anatoly Dritschilo, M.D.
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address401 Professional Drive,Suite 260
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20879
Phone1-240-403-4212

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Anatoly Dritschilo, M.D.
  • Chairman of the Board and Chief Executive Officer
  • 399.18K
  • Dr. Tyvin A. Rich, M.D.
  • Chief Clinical Officer
  • 263.23K
  • Dr. Mira Jung, M.A.,PhD
  • Chief Scientific Officer, Biology
  • --
  • Timothy J. Lorber
  • Chief Financial Officer
  • --
  • Peter Dritschilo
  • President and Chief Operating Officer
  • 314.01K
  • Michael P. Vander Hoek
  • Vice President, Operations and Regulatory and Principal Accounting Officer
  • 302.53K
  • Dr. Milton Brown, M.D.,PhD
  • Director
  • --
  • Steven Richards, C.P.A.
  • Independent Director
  • --
  • Dr. Bette Jacobs, PhD
  • Independent Director
  • --
  • Joshua Schafer, M.B.A.
  • Independent Director
  • --
  • Dr. Christoopher H. Senanayake, PhD
  • Independent Director
  • --

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More